E64FC26 is a pan-Inhibitor of the Protein Disulfide Isomerase (PDI) Family
Multiple myeloma (MM) is an incurable hematological malignancy. MM results in the accumulation of clonal plasma cells within the bone marrow. The natural biology of the plasma cell makes MM uniquely sensitive to disruptions in protein homeostasis. Subsequently, it proposes targeting protein folding as a strategy for the treatment...
CM10 is a Selective Aldehyde Dehydrogenase 1A Family Inhibitor
The aldehyde dehydrogenase (ALDH) superfamily has 19 protein-coding family members with varying tissue or development expression. In addition, ALDHs metabolize endogenous and exogenous aldehydes to their corresponding carboxylic acids to prevent the accumulation of toxic aldehydes. Besides, ALDH1A enzymes are also involved in the biosynthesis of retinoic acid (RA)....
Balixafortide is a Selective and Well-Tolerated Peptidic CXCR4 Antagonist
Despite the introduction of new targeted therapies and cytotoxic agents, chemotherapy-pretreated metastatic breast cancer (MBC) remains an essentially incurable disease with only moderate median overall survival (OS). over 20 human tumor types overexpress C-X-C chemokine receptor type 4 (CXCR4). CXCR4 levels correlate with aggressive metastatic phenotypes and negative prognosis...
DB1976 is a Fully Efficacious Transcription Factor PU.1 Inhibitor
ETS transcription factors mediate a wide array of cellular functions and are attractive targets for pharmacological control of gene regulation. Transcription factors (TFs) are central to many cellular processes and account for 5-10% of genes in eukaryotes. Besides, sequence-specific binding is an obligate step in ETS-mediated gene activation. So...
JBJ-04-125-02 is a Mutant-Selective and Orally Active EGFR Inhibitor
Epidermal growth factor receptor (EGFR) is a transmembrane receptor protein in humans. The discovery of activating mutations in EGFR detected in 10% to 30% of patients with non–small cell lung cancer (NSCLC). In addition, it has revolutionized the treatment of this disease. Until recently, EGFR tyrosine kinase inhibitors (TKI), including...
PS315, an Allosteric PKC Inhibitor Binding to the PIF-Pocket
Members of the protein kinase C (PKC) family are regulated by phosphorylation and by an N-terminal extension of the catalytic domain. In addition, AGC kinases are a group of protein kinases comprising PKA, protein kinase G, and PKC families. They typically have three conserved phosphorylation sites. Besides, all PKCs...
CCT36776 is a PROTAC-based Pirin Protein Degradation Probe
Proteolysis targeting chimeras (PROTACs) are heterobifunctional molecules. It induces rapid and selective protein degradation, via the proteasome. PROTACs contain two different ligands connected by a linker, one portion of the molecule engages the target protein. While the other, attach via a flexible linker, recruits an E3 ubiquitin ligase to...